Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Sanguine Corp (SGNC) since 2007 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data at Sanguine Corp. Table 2 shows the detailed insider transactions. The reporting company's CIK number is 926287.
Total stock buying since 2007: $40,000.
Total stock sales since 2007: $9,075.
Total stock option exercises since 2007: $0.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2008 | 1,000,000 | $40,000 | 0 | $0 | 0 | $0 |
| 2007 | 0 | $0 | 75,000 | $9,075 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2008-06 | 1,000,000 | $40,000 | 0 | $0 | 0 | $0 |
| 2007-04 | 0 | $0 | 75,000 | $9,075 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2008-06-12 | Nelson David E (Chief Financial Officer) | Buy | 1,000,000 | .04 | 40,000 |
| 2007-04-05 | Kunkel Edward L (Director) | Sale | 25,000 | .12 | 3,025 |
| 2007-04-04 | Kunkel Edward L (Director) | Sale | 50,000 | .12 | 6,050 |
Insider trading activities including stock purchases, stock sales, and option exercises of SGNC listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Sanguine Corp (symbol SGNC, CIK number 926287) see the Securities and Exchange Commission (SEC) website.